Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi‐centre clinical trial

Diabetic foot infections continue to be a major challenge for health care delivery systems. Following encouraging results from a pilot study using a novel purified reconstituted bilayer matrix (PRBM) to treat chronic diabetic foot ulcers (DFUs), we designed a prospective, multi‐centre randomised tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, David G., Orgill, Dennis P., Galiano, Robert D., Glat, Paul M., Kaufman, Jarrod P., Carter, Marissa J., DiDomenico, Lawrence A., Zelen, Charles M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284637/
https://www.ncbi.nlm.nih.gov/pubmed/35001559
http://dx.doi.org/10.1111/iwj.13715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284637/
https://www.ncbi.nlm.nih.gov/pubmed/35001559
http://dx.doi.org/10.1111/iwj.13715

Ejemplares similares